Do you really think Merck just signed a new deal without doing diligence?
Previous small trials were a good indicator. This trial of 750 is the real deal..........FDA want to see results over a large number of patients.
If we are looking at a PFS of 36 months then that takes us to late 2027. Perfect timing for an aquisition and Merck get their new patents and ongoing sales stream. We need to be a bit more patient ( i have owned since early PRR) as Merck are probably happy to string this out for 3 more years testing all options before their own Keytruda patent runs out.
Do you really think Merck just signed a new deal without doing...
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
-0.100(23.0%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 40.0¢ | 23.0¢ | $16.23M | 50.19M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 704297 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 102135 | 2 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |